S

Squarepoint Capital

957 employees

Squarepoint Capital is a leading global investment management firm that develops quantitative investment strategies.

Investor insights

Sectors invested in

Health Care4

Medical Device3

Biotechnology2

Medical2

fertility clinics1

large volume drug delivery device1

combination product1

wearable injector1

wearable drug delivery device1

drug delivery system1

high-viscosity1

subcutaneous drug delivery1

enFuse1

patient-centric technology1

injector1

delivery system1

on-body infusor1

Life Science1

Manufacturing1

Hospital1

Funding rounds participated in

$101M sweet spot round size

Most of their 7 investments are in rounds between $49M and $120M

Investor type

Venture Capital

Basic info

Industry

financial services

Sectors

Financial Services

Date founded

2014

Investments made

U

Undisclosed raised $55M on May 17, 2023

Investors: Squarepoint Capital

B

BioVentrix raised $49M on April 13, 2023

Investors: Taglich Brothers, Inc., Research Division, Andera Partners, Richmond Brothers, Inc. and Squarepoint Capital

G

GrubMarket Inc. raised $120M on September 28, 2022

Investors: Walleye Capital, Celtic House Asia Partners, Portfolia, Liberty Street Advisors, Apeira Capital, Grosvenor Food & AgTech, 301 INC and Squarepoint Capital

K

Kindbody raised $27M on September 6, 2022

Investors: G9 Ventures, Distributed Ventures, GV and Squarepoint Capital

C

Cera raised $157M on August 4, 2022

Investors: Schroders Capital, Guinness Ventures, 8090 Partners, yabeo, Oltre Venture, Kairos Society and Squarepoint Capital

I

Impulse Dynamics raised $101M on May 12, 2022

Investors: Abiomed, Kennedy Lewis Investment Management LLC, - and Squarepoint Capital

E

Enable Injections, Inc. raised $215M on January 27, 2022

Investors: CincyTech USA, Wood Creek Capital Management (Barings), Magnetar Capital, Ohio Innovation Fund and Squarepoint Capital